Skip to main content
CivixlyCivixly
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Menu
HomeFederal GovernmentState GovernmentLearnCommunityFeedback
Sign InCreate Account
Civixly

Find representatives, follow federal and state legislation, and connect public records to the people and institutions responsible for them.

Explore

Federal governmentState governmentCivics guides

About the data

About CivixlyMethodologyData sources

Help improve Civixly

Send feedback or a correctionCommunity

State Government / Indiana / Legislation / SB 91

SB 91Session 2026SenateBecame law

Syringe exchange program.

Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.

Latest development · Mar 10, 2026

Public Law 144

Your view
Source record ↗
Session
2026
Introduced
Dec 9, 2025
Latest passage
Feb 27, 2026
TopicsSponsorsActionsDiscussion

Topics and classification

Civixly topics

HealthJustice & Public Safety

Source subjects

ADDICTION SERVICES; Illicit Drugs, Prescription Drugs, Substances, and AlcoholAGENCIES; Department of Health (IDOH)CRIMINAL LAW AND PROCEDURE; Illicit Drugs, Substances, and Alcohol OffensesHEALTH; Communicable Diseases, Infectious DiseasesHEALTH; GenerallyHEALTH; Prescription Drugs and Medications

Document type

Bill

Sponsors

Primary sponsors are listed before cosponsors and other sponsoring entities.

Primary sponsorBrett Clark
Primary sponsorEd Charbonneau
Primary sponsorEdward Clere
Primary sponsorMichael Crider
cosponsorAlex Zimmerman
cosponsorEthan Lawson
coauthorKyle Walker
coauthorLa Keisha Jackson
coauthorLonnie Randolph
coauthorMike Bohacek
coauthorRodney Pol
coauthorShelli Yoder
cosponsorVictoria Garcia Wilburn

Action timeline

Newest action first. Action language is supplied by the state source.

View full action timeline33 actions⌄
  1. Mar 10, 2026

    Public Law 144

    Became LawSenate
  2. Mar 10, 2026

    Bill Became Law on 8th Day Without Signature

    Senate
  3. Feb 27, 2026

    Signed by the President Pro Tempore

    PassageSenate
  4. Feb 27, 2026

    Signed by the Speaker

    PassageHouse
  5. Feb 27, 2026

    Signed by the President of the Senate

    PassageSenate
  6. Feb 25, 2026

    Senate concurred with House amendments; Roll Call 273: yeas 38, nays 10

    Senate
  7. Feb 19, 2026

    Returned to the Senate with amendments

    ReceiptHouse
  8. Feb 19, 2026

    Motion to concur filed

    FilingSenate
  9. Feb 18, 2026

    Third reading: passed; Roll Call 271: yeas 70, nays 22

    PassageReading 3Reading 3House
  10. Feb 17, 2026

    Amendment #11 (Mayfield) prevailed; voice vote

    Amendment PassageHouse
  11. Feb 17, 2026

    Second reading: amended, ordered engrossed

    Reading 2House
  12. Feb 17, 2026

    Representatives Zimmerman, Garcia Wilburn added as cosponsors

    House
  13. Feb 17, 2026

    Amendment #14 (Clere) prevailed; voice vote

    Amendment PassageHouse
  14. Feb 17, 2026

    Amendment #12 (Ireland) prevailed; voice vote

    Amendment PassageHouse
  15. Feb 10, 2026

    Committee report: amend do pass, adopted

    Committee PassageHouse
  16. Jan 29, 2026

    First reading: referred to Committee on Public Health

    Reading 1Referral CommitteeHouse
  17. Jan 28, 2026

    Referred to the House

    ReferralSenate
  18. Jan 28, 2026

    Representative Goss-Reaves removed as cosponsor

    House
  19. Jan 27, 2026

    Cosponsors: Representatives Lawson, Goss-Reaves

    Senate
  20. Jan 27, 2026

    Third reading: passed; Roll Call 93: yeas 33, nays 13

    PassageReading 3Reading 3Senate
  21. Jan 27, 2026

    House sponsor: Representative Clere

    Senate
  22. Jan 27, 2026

    Senator Pol added as coauthor

    Senate
  23. Jan 26, 2026

    Second reading: amended, ordered engrossed

    Reading 2Senate
  24. Jan 26, 2026

    Amendment #2 (Crider) prevailed; voice vote

    Amendment PassageSenate
  25. Jan 20, 2026

    Senator Randolph added as coauthor

    Senate
  26. Jan 13, 2026

    Senators Bohacek, Jackson L added as coauthors

    Senate
  27. Jan 12, 2026

    Senator Walker K added as coauthor

    Senate
  28. Jan 8, 2026

    Senator Charbonneau added as second author

    Senate
  29. Jan 8, 2026

    Committee report: do pass, adopted

    Committee PassageSenate
  30. Jan 8, 2026

    Senator Clark added as third author

    Senate
  31. Jan 8, 2026

    Senator Yoder added as coauthor

    Senate
  32. Dec 9, 2025

    Authored by Senator Crider

    Senate
  33. Dec 9, 2025

    First reading: referred to Committee on Health and Provider Services

    Reading 1Referral CommitteeSenate

SB 91 discussion

0 comments

Sign in to join the discussion.Comments are publicly visible.

Loading comments...

State legislative data provided by Open States and linked legislature sources when available.

Civixly tracks state bill actions, passage dates, and sponsors. Member-level state roll-call histories are not included.

Source data last updated May 13, 2026.